Tuesday, November 20, 2018

Alzamend Neuro™ Secures New Licenses from USF to Treat Alzheimer’s Disease

Alzamend Neuro™ Secures New Licenses from USF to Treat Alzheimer’s Disease Cocrystal Lithium-Based Therapy, “LiProSal™” Targets the Reduction of Agitation in Patients with AD Salt Lake City, UT - (Globe...
0FansLike
0FollowersFollow
100FollowersFollow
692FollowersFollow

Recent Posts